Calcipotriol and Betamethasone Dipropionate for the Treatment of Psoriasis: A 52-Week Study

Skin Therapy Letter-Family Practice Edition

关键词: Calcipotriol;    Betamethasone Dipropionate;    Psoriasis;   

DOI  :  

学科分类：医学（综合）

来源: Skin Therapy Letter-Family Practice Edition

【 摘 要 】

Psoriasis is a common skin disease affecting 1%-3% of the world’s population with significant impacts on quality of life. There is a great need for therapies that are efficacious and safe, not only for the short-term, but also for long-term management. Dovobet®/ Daivobet®/ Taclonex® is a product combining two molecules, calcipotriol and betamethasone dipropionate, that may offer psoriatic patients with an option for maintenance therapy. The efficacy and safety of this combined formulation when used over a 4-week period is well documented. A recent publication in the British Journal of Dermatology discusses the safety of this product when used for 52 weeks.1

【 授权许可】

Unknown